Sensitivity and specificity of intracoronary injection of acetylcholine for the induction of coronary artery spasm

Division of Cardiology, Kumamoto University Medical School, Japan.

Intracoronary injection of acetylcholine has been shown to induce coronary spasm in patients with variant angina. To examine its sensitivity and specificity, incremental doses of acetylcholine (20, 50 and 100 micrograms into the left coronary artery and 20 and 50 micrograms into the right coronary artery) were injected into the coronary artery or arteries in 70 patients with variant angina (Group 1) (mean age 57 years) and 93 patients without variant angina or angina at rest (Group 2) (mean age 54 years). Forty patients of the latter group had atypical chest pain, 16 cardiomyopathy, 14 arrhythmia, 11 valvular disease, 7 stable effort angina due to advanced coronary artery disease, 3 congenital heart disease and 2 hypertension. A temporary cardiac pacemaker set at 40 to 50 beats/min was positioned in the right ventricle. Coronary spasm was defined as total occlusion or severe vasoconstriction associated with chest pain or ischemic ST changes on the electrocardiogram or both. In Group 1, acetylcholine induced spasm in 63 (90%) of the 70 patients in the artery or arteries predicted to be responsible for spontaneous attacks. In Group 2, acetylcholine induced coronary spasm only in one patient with effort angina and advanced coronary artery disease although lesser degrees of vasoconstriction (less than or equal to 75% of the luminal diameter) occurred in most patients after acetylcholine (specificity of acetylcholine thus was 99%). In conclusion, intracoronary injection of acetylcholine is sensitive and reliable for the induction of coronary spasm.

This article has been cited by other articles:

				M. R. Summers, A. Lerman, R. J. Lennon, C. S. Rihal, and A. Prasad Myocardial ischaemia in patients with coronary endothelial dysfunction: insights from body surface ECG mapping and implications for invasive evaluation of chronic chest pain Eur. Heart J., November 2, 2011; 32(22): 2758 - 2765. [Abstract] [Full Text] [PDF]

				R. Murakami, T. Osanai, H. Tomita, S. Sasaki, A. Maruyama, K. Itoh, Y. Homma, and K. Okumura p122 Protein Enhances Intracellular Calcium Increase to Acetylcholine: Its Possible Role in the Pathogenesis of Coronary Spastic Angina Arterioscler Thromb Vasc Biol, October 1, 2010; 30(10): 1968 - 1975. [Abstract] [Full Text] [PDF]

				H. Nakagawa, Y. Morikawa, Y. Mizuno, E. Harada, T. Ito, K. Matsui, Y. Saito, and H. Yasue Coronary Spasm Preferentially Occurs at Branch Points: An Angiographic Comparison With Atherosclerotic Plaque Circ Cardiovasc Interv, April 1, 2009; 2(2): 97 - 104. [Abstract] [Full Text] [PDF]

				C. Van Mieghem, M. Sabbe, and D. Knockaert The Clinical Value of the ECG in Noncardiac Conditions Chest, April 1, 2004; 125(4): 1561 - 1576. [Abstract] [Full Text] [PDF]

				H. Soejima, A. Irie, S. Miyamoto, I. Kajiwara, S. Kojima, J. Hokamaki, T. Sakamoto, T. Tanaka, M. Yoshimura, Y. Nishimura, et al. Preference Toward a T-Helper Type 1 Response in Patients With Coronary Spastic Angina Circulation, May 6, 2003; 107(17): 2196 - 2200. [Abstract] [Full Text] [PDF]

				K. Kodama-Takahashi, K. Ohshima, K. Yamamoto, T. Iwata, M. Hamada, K. Hiwada, and E. Murakami Occurrence of Transient U-Wave Inversion During Vasospastic Anginal Attack Is Not Related to the Direction of Concurrent ST-Segment Shift* Chest, August 1, 2002; 122(2): 535 - 541. [Abstract] [Full Text] [PDF]

				Y. Tanabe, E. Itoh, K. Suzuki, M. Ito, Y. Hosaka, I. Nakagawa, and M. Kumakura Limited role of coronary angioplasty and stentingin coronary spastic angina with organic stenosis J. Am. Coll. Cardiol., April 3, 2002; 39(7): 1120 - 1126. [Abstract] [Full Text] [PDF]

				Y. Kawai, E. Tsukamoto, Y. Nozaki, K. Morita, M. Sakurai, and N. Tamaki Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain J. Am. Coll. Cardiol., December 1, 2001; 38(7): 1888 - 1894. [Abstract] [Full Text] [PDF]

				K. Okumura, T. Osanai, T. Kosugi, H. Hanada, H. Ishizaka, T. Fukushi, T. Kamada, T. Miura, T. Hatayama, T. Nakano, et al. Enhanced phospholipase C activity in the cultured skin fibroblast obtained from patients with coronary spastic angina: possible role for enhanced vasoconstrictor response J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1847 - 1852. [Abstract] [Full Text] [PDF]

				K. Kodama, Y. Shigematsu, M. Hamada, K. Hiwada, Y. Kazatani, K. Matsuzaki, and E. Murakami The Effect of Coronary Vasospasm on the Direction of ST-Segment Deviation in Patients With Both Hypertrophic Cardiomyopathy and Vasospastic Angina Chest, May 1, 2000; 117(5): 1300 - 1308. [Abstract] [Full Text] [PDF]

				K. Miwa, K. Nakagawa, N. Yoshida, Y. Taguchi, and H. Inoue Lipoprotein(a) is a risk factor for occurrence of acute myocardial infarction in patients with coronary vasospasm J. Am. Coll. Cardiol., April 1, 2000; 35(5): 1200 - 1205. [Abstract] [Full Text] [PDF]

				J. F. Beltrame, S. Sasayama, and A. Maseri Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and caucasian patients J. Am. Coll. Cardiol., May 1, 1999; 33(6): 1442 - 1452. [Abstract] [Full Text] [PDF]

				H. Suzuki, S. Kawai, T. Aizawa, K. Kato, S. Sunayama, R. Okada, and H. Yamaguchi Histological evaluation of coronary plaque in patients with variant angina: relationship between vasospasm and neointimal hyperplasia in primary coronary lesions J. Am. Coll. Cardiol., January 1, 1999; 33(1): 198 - 205. [Abstract] [Full Text] [PDF]

				M. Hamada, Y. Kazatani, K. Matsuzaki, E. Murakami, Y. Shigematsu, K. Hiwada, and K. Kodama Clinical Characteristics in Japanese Patients with Coexistent Hypertrophic Cardiomyopathy and Coronary Vasospasm Angiology, September 1, 1998; 49(9): 849 - 855. [Abstract] [PDF]

				M. Suzuki, M. Nishizaki, M. Arita, T. Ashikaga, N. Yamawake, T. Kakuta, F. Numano, and M. Hiraoka Increased QT Dispersion in Patients With Vasospastic Angina Circulation, August 4, 1998; 98(5): 435 - 440. [Abstract] [Full Text] [PDF]

				T. Nakano, T. Osanai, H. Tomita, M. Sekimata, Y. Homma, and K. Okumura Enhanced Activity of Variant Phospholipase C-{delta}1 Protein (R257H) Detected in Patients With Coronary Artery Spasm Circulation, April 30, 2002; 105(17): 2024 - 2029. [Abstract] [Full Text] [PDF]